Zydus receives USFDA approval to initiate Phase II clinical trial of ZYIL1 for Parkinson’s disease
ZYIL1 is a novel oral small molecule NLRP3 inhibitor. Studies have demonstrated that ZYIL1 is highly potent and can suppress…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
USFDA
Zydus receives final approval from the USFDA for Darunavir Tablets 600 mg and 800 mg
Darunavir is a protease inhibitor antiviral medicine that prevents Human Immunodeficiency Virus (HIV-1) from multiplying in the…
New CAR-T therapies in South Korea to face stringent regulatory oversight: GlobalData
The Korean Ministry of Food and Drug Safety (MFDS) has recently mandated the reporting of any suspected adverse reactions,…
Indoco Remedies gets tentative USFDA approval for Canagliflozin Tablets
Canagliflozin improves glycemic control in adults with type 2 diabetes mellitus
Zydus gets final USFDA nod for Methylene Blue Injection
Methylene Blue Injection is an oxidation-reduction agent indicated for the treatment of pediatric and adult patients with acquired…
Karuna Therapeutics’ NDA for KarXT accepted by USFDA
If approved, KarXT would represent the first new pharmacological approach to treating schizophrenia in several decades
Aurobindo Pharma gets USFDA nod for HIV drug
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Darunavir…
USFDA approves SpringWorks Therapeutics’ non-cancerous tumor treatment
Shares of the company were up about 18 per cent after the bell
Strides gets USFDA approval for generic Suprep Bowel Prep Kit
The product belongs to a group of medicines prescribed to those who are required to undergo a colon cleanse prior to a colonoscopy
Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced…
Neutropenia is characterised by persistently low levels of neutrophils due to the use of chemotherapy and other types of…